Journal
JOURNAL OF CONTROLLED RELEASE
Volume 238, Issue -, Pages 263-271Publisher
ELSEVIER
DOI: 10.1016/j.jconrel.2016.07.048
Keywords
Nanomedicine; Nanocapsules; Nanoparticles; Drug delivery; Anti-cancer; Oncologicals
Funding
- European Commission FP7 for the LYMPHOTARG (ERA-NET EuroNanoMed Program-ISCIII) [PS09/02670]
- NICHE projects (ERA-NET EuroNanoMed II framework by ISCIII through CIBER-BBN)
- Xunta de Galicia (Isidro Parga Pondal Fellowhsip and Competitive Reference Groups-FEDER Funds) [GRC2013-043]
- Doctoral School of Biomedical Sciences and Health Technologies - University of Santiago de Compostela
Ask authors/readers for more resources
The design of nanomedicines with suitable physicochemical characteristics for the lymphatic targeting of drugs is critical in order to reach the lymph nodes, where metastatic cells often accumulate. Based on the known effect of particle size and surface hydrophilicity on the capacity of nanocarriers to reach the lymph nodes, here we report the formation and characterization of 100 nm polyglutamic acid-polyethylene glycol (PGA-PEG) nanocapsules together with the assessment of their potential for the treatment of cancer with lymphatic metastatic spread. To this purpose, we first studied the biodistribution of fluorescently labeled PGA-PEG nanocapsules (100 nm), following, either intravenous or subcutaneous administration. The results confirmed the accumulation of nanocapsules in the lymphatic system, especially upon subcutaneous administration. Next, we evaluated the efficacy and toxicity of the docetaxel-loaded nanocapsules in an orthotopic lung cancer model that metastasizes to the lymph nodes. As expected from the rational design, DCX-loaded PGA-PEG nanocapsules exhibited a greatly enhanced antitumoral efficacy and a reduced toxicity when compared with the commercial formulation Taxotere (R). Furthermore, the administration of DCX-loaded PGA-PEG nanocapsules resulted in the practical elimination of the metastatic load in the mediastinal lymph nodes, whereas the treatment with the commercial formulation had a minor effect. Overall, these findings underscore the potential of PGA-PEG nanocapsules for the delivery of anticancer drugs to both, the tumor tissue and the metastatic lymph nodes. Therefore, they represent a promising therapy for the treatment of lung metastatic cancer. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available